A. Shelemba

Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?

A. A. Sergeev, E. Volosnikova, L. Karpenko, 2022, Viruses.

INFLUENCE OF EBOLA VIRUS VP24 PROTEIN RECOMBINANT VERSION ON INDUCTION OF INTERFERON

S. Kolesnikov, S. Rams, A. Shelemba, 2011 .

Cell and Organism Technologies for Assessment of the SARS-CoV-2 Infectivity in Fluid Environment

A. Chepurnov, A. Shestopalov, Y. Kononova, 2022, Bulletin of Experimental Biology and Medicine.

Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems

E. Volosnikova, L. Karpenko, A. Rudometov, 2022, Vaccines.

Inhibitory activity of aqueous extracts of tea compositions, individual ingredients for their preparation and some plants against replication of Herpes simplex virus type 2 in vitro

A. Chepurnov, A. Shestopalov, M. Magomedov, 2022, South of Russia: ecology, development.

Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology

A. Chepurnov, E. I. Kazachinskaya, K. Sharshov, 2021, Bulletin of Experimental Biology and Medicine.